Company / Current Liabilities
BioRestorative Therapies, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$3.7M
FY2025
5-year range
$363.8K / $3.7M
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 10 years, ranging from $363,822 in FY2021 to $14M in FY2019.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +28.9%.
Increased from $3M to $4M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +103.7%
- 5-Year CAGR
- +28.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +28.9%, indicating consistent growth.
- In FY2025, current liabilities decreased 0.7% year-over-year.
- Peak current liabilities was recorded in FY2019.
- Lowest current liabilities in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.7M | -0.7% |
| FY2024 | $3.7M | +43.8% |
| FY2023 | $2.6M | +492.2% |
| FY2022 | $440.3K | +21.0% |
| FY2021 | $363.8K | -65.2% |
| FY2020 | $1.0M | -92.4% |
| FY2019 | $13.7M | +48.3% |
| FY2018 | $9.3M | +10.8% |
| FY2017 | $8.4M | +42.9% |
| FY2016 | $5.8M | +4.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026